| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Net Sales | $1.7B (flat YoY) | $1.7B (+4% YoY) | +400 bps acceleration |
| Organic Sales Growth | 1% decline (adj. for timing) | 2% growth | +300 bps sequential improvement |
| Operating EBITDA Margin | 24.2% (+80 bps YoY) | 24.6% (+230 bps YoY) | +40 bps sequential expansion |
| Healthcare & Water Sales | $821M (+4% YoY) | $806M (+6% YoY) | +200 bps acceleration despite lower absolute |
| Healthcare Organic Growth | Mid-single digits | High single digits | Clear acceleration in core growth driver |
| Water Organic Growth | Low single digits | Down low-to-mid single digits | Sharp deceleration, even ex-Middle East impact |
| Diversified Industrials Sales | $872M (-3% YoY) | $875M (+3% YoY) | +600 bps turnaround |
| Diversified Industrials Organic | Down 2% (adj.) | About flat | +200 bps improvement but still no growth |
| Free Cash Flow Conversion | Expected >90% for 2026 | 65% in Q1 | Solid start, maintains full-year target |
| Full Year EPS Guidance | $2.25-2.30 | $2.35-2.40 | +$0.10 raise, 40% reported growth |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.